SHR0302 Base Gel + SHR0302 Base Gel Placebo
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Preoperative Sedation of Adults
Conditions
Preoperative Sedation of Adults
Trial Timeline
Jun 19, 2024 → Jul 31, 2024
NCT ID
NCT07098117About SHR0302 Base Gel + SHR0302 Base Gel Placebo
SHR0302 Base Gel + SHR0302 Base Gel Placebo is a phase 1 stage product being developed by Jiangsu Hengrui Medicine for Preoperative Sedation of Adults. The current trial status is completed. This product is registered under clinical trial identifier NCT07098117. Target conditions include Preoperative Sedation of Adults.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07098117 | Phase 1 | Completed |
Competing Products
2 competing products in Preoperative Sedation of Adults
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Dexmedetomidine hydrochloride nasal spray + Dexmedetomidine hydrochloride nasal spray blank preparation. | Jiangsu Hengrui Medicine | Phase 1 | 33 |
| dexmedetomidine nasal spray + dexmedetomidine hydrochloride nasal spray blank preparation | Jiangsu Hengrui Medicine | Phase 2/3 | 65 |